Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis

NCT01324466 is registered in ClinicalTrials.gov with NanoBio Corporation as lead sponsor.

NCT NCT01324466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01324466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis
Lead sponsor
NanoBio Corporation
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
January 31, 2012
Enrollment
847 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent herpes labialis